“Clinical trials referral resource. Current clinical trials for the proteosome inhibitor PS-341”, Oncology, vol. 14, pp. 1589-15901593-94
1597, 2000.
, “Clinical trials referral resource. Current clinical trials for the proteasome inhibitor PS-341.”, Oncology (Williston Park), vol. 14, no. 11, pp. 1589-90, 1593-4, 1597, 2000.
, “Comparison of systemic and mucosal delivery of 2 canarypox virus vaccines expressing either HIV-1 genes or the gene for rabies virus G protein.”, J Infect Dis, vol. 189, no. 7, pp. 1221-31, 2004.
, “Component-resolved analysis of IgA, IgE, and IgG4 during egg OIT identifies markers associated with sustained unresponsiveness.”, Allergy, vol. 71, no. 11, pp. 1552-1560, 2016.
, “Clinical trials referral resource. Clinical trials with the farnesyl transferase inhibitor R115777.”, Oncology (Williston Park), vol. 13, no. 11, p. 1527, 1530, 1533, 1999.
, “Implementation of a Medication and Supply Inventory and Resupply Process - Increasing the Efficiency of the Tracking and Distribution of Supplies in Clinical Trials”, in Society for Clinical Trials (SCT) 36th Annual Meeting (2015), Arlington, VA, 2015.
, “Peripheral Retinal Changes Associated with Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 12 by the Age-Related Eye Disease Study 2 Optos PEripheral RetinA (OPERA) Study Research G”, Ophthalmology, vol. 124, no. 4, pp. 479-487, 2017.
, “Effect of long-chain ω-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.”, JAMA Intern Med, vol. 174, no. 5, pp. 763-71, 2014.
, , “Design of the NIDA clinical trials network validation study of tobacco, alcohol, prescription medications, and substance use/misuse (TAPS) tool.”, Contemp Clin Trials, vol. 50, pp. 90-7, 2016.
, “Using electronic health record data for substance use Screening, Brief Intervention, and Referral to Treatment among adults with type 2 diabetes: Design of a National Drug Abuse Treatment Clinical Trials Network study.”, Contemp Clin Trials, vol. 46, pp. 30-38, 2016.
, “Testing and linkage to HIV care in China: a cluster-randomised trial.”, Lancet HIV, vol. 4, no. 12, pp. e555-e565, 2017.
, “Design of the Buprenorphine Physician-Pharmacist Collaborative Care of Patients with Opioid Use Disorder. ”, in 81st Annual Scientific Meeting of the College of Problems on Drug Disorders (CPDD), , San Antonio, TX. , 2019.
, “DSM-5 substance use disorders among adult primary care patients: Results from a multisite study.”, Drug Alcohol Depend, vol. 179, pp. 42-46, 2017.
, ,
“Impact of antioxidants, zinc, and copper on cognition in the elderly: a randomized, controlled trial.”, Neurology, vol. 63, no. 9, pp. 1705-7, 2004.
, “Impact of Antioxidants, Zinc, and Copper on Cognition in the Elderly: A Randomized, Controlled Trial”, Neurology, vol. 63, pp. 1705-1707, 2004.
, “Induction of human T-Cell-Mediated immune responses after primary and secondary smallpox vaccination”, J Infectious Diseases, vol. 190, pp. 1286-94, 2004.
, “Genome-wide analysis of disease progression in age-related macular degeneration.”, Hum Mol Genet, vol. 27, no. 5, pp. 929-940, 2018.
, “Randomized, Double-Blind, Placebo-Controlled Trial of Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for the Treatment of Idiopathic Pneumonia Syndrome After Allogeneic Stem Cell Transplantation: BMT CTN Protocol”, Biol Blood Marrow Transplant, vol. 20, pp. 858-864, 2014.
, “Randomized, double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: enbrel (etanercept) for the treatment of idiopathic pneumonia syndrome after allogeneic stem cell transplantation: blood and marrow transplant clinical trials ne”, Biol Blood Marrow Transplant, vol. 20, no. 6, pp. 858-64, 2014.
, “Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning”, Nature Medicine, vol. 9, pp. 416-423, 2003.
, “Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning.”, Nat Med, vol. 9, no. 4, pp. 416-23, 2003.
, “Monitoring Medication Adherence Electronically: Considerations and a Case Study”, in Society for Clinical Trials 35th Annual Meeting, Philadelphia, PA, 2014.
, “Optimizing an Existing Data Collection System for Tablet Compatibility: Considerations and a Case Study”, in Society for Clinical Trials 35th Annual Meeting, Philadelphia, PA, 2014.
,